ADXS Advaxis Inc

Price (delayed)

$0.861

Market cap

$1.57M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$8

Enterprise value

-$40.13M

Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live ...

Highlights
The quick ratio has soared by 113% from the previous quarter and by 21% YoY
The debt has dropped by 99% year-on-year and by 15% since the previous quarter
ADXS's revenue is down by 50% from the previous quarter and by 13% YoY
The gross profit has decreased by 50% from the previous quarter and by 13% YoY

Key stats

What are the main financial stats of ADXS
Market
Shares outstanding
1.82M
Market cap
$1.57M
Enterprise value
-$40.13M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.04
Price to sales (P/S)
0.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-24.69
Earnings
Revenue
$1.63M
EBIT
-$14.2M
EBITDA
-$13.85M
Free cash flow
-$16.34M
Per share
EPS
-$8
Free cash flow per share
-$8.98
Book value per share
$21.18
Revenue per share
$0.89
TBVPS
$23.76
Balance sheet
Total assets
$46.5M
Total liabilities
$3.72M
Debt
$34,000
Equity
$38.55M
Working capital
$39.4M
Liquidity
Debt to equity
0
Current ratio
11.59
Quick ratio
11.22
Net debt/EBITDA
3.01
Margins
EBITDA margin
-852%
Gross margin
100%
Net margin
-876.9%
Operating margin
-1,168.5%
Efficiency
Return on assets
-28.5%
Return on equity
-33.7%
Return on invested capital
N/A
Return on capital employed
-33.2%
Return on sales
-873.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ADXS stock price

How has the Advaxis stock price performed over time
Intraday
0%
1 week
-11.24%
1 month
43.5%
1 year
-33.77%
YTD
29.09%
QTD
29.09%

Financial performance

How have Advaxis's revenue and profit performed over time
Revenue
$1.63M
Gross profit
$1.63M
Operating income
-$18.99M
Net income
-$14.25M
Gross margin
100%
Net margin
-876.9%
Advaxis's operating margin has shrunk by 102% QoQ but it has increased by 3.3% YoY
The net margin has dropped by 59% since the previous quarter but it has increased by 28% year-on-year
ADXS's revenue is down by 50% from the previous quarter and by 13% YoY
The gross profit has decreased by 50% from the previous quarter and by 13% YoY

Growth

What is Advaxis's growth rate over time

Valuation

What is Advaxis stock price valuation
P/E
N/A
P/B
0.04
P/S
0.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-24.69
Advaxis's EPS has soared by 69% YoY and by 29% from the previous quarter
The P/B is 97% below the last 4 quarters average of 1.2
ADXS's equity is up by 2.6% YoY
The P/S is 95% lower than the last 4 quarters average of 17.5
ADXS's revenue is down by 50% from the previous quarter and by 13% YoY

Efficiency

How efficient is Advaxis business performance
Advaxis's ROS has plunged by 59% from the previous quarter but it has increased by 28% YoY
The company's return on equity rose by 50% YoY and by 21% QoQ
ADXS's ROA is up by 46% YoY and by 20% from the previous quarter

Dividends

What is ADXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ADXS.

Financial health

How did Advaxis financials performed over time
The quick ratio has soared by 113% from the previous quarter and by 21% YoY
The current ratio has surged by 111% since the previous quarter and by 17% year-on-year
The debt is 100% smaller than the equity
ADXS's debt to equity has plunged by 100% YoY
The debt has dropped by 99% year-on-year and by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.